Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mahachai Hospital PCLBKK:M-CHAI +0.52%73 EBITDA Margin % is 17.57% as of Mar. 2026, which is 1% below its 10-year median of 17.79. GuruFocus rates BKK:M-CHAI with a GF Score™ of 73/100 and a GF Value™ of ฿28.66 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Mahachai Hospital PCL ranks better than 70.27% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Mahachai Hospital PCL EBITDA Margin % Related Terms
Mahachai Hospital PCL EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Mahachai Hospital PCL's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:M-CHAI vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Mahachai Hospital PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mahachai Hospital PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mahachai Hospital PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Mahachai Hospital PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mahachai Hospital PCL (BKK:M-CHAI) has a EBITDA Margin % of 17.57% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Mahachai Hospital PCL and its competitors. This is near median its historical median of 17.79. Over the past decade, Mahachai Hospital PCL's EBITDA Margin % has ranged from 9.10 to 23.99. According to the industry distribution chart, Mahachai Hospital PCL ranks #198 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 29.7%.
Is Mahachai Hospital PCL's EBITDA Margin % too high?
Mahachai Hospital PCL's current EBITDA Margin % of 17.57% is near median its 10-year median of 17.79. Over the past 10 years, this metric has ranged from a low of 9.10 to a high of 23.99. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Mahachai Hospital PCL's value of 17.57% is 71.7% above this industry median. Based on the distribution chart, Mahachai Hospital PCL ranks #198 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Mahachai Hospital PCL has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mahachai Hospital PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mahachai Hospital PCL ranks #198 out of 666 companies for EBITDA Margin %. This puts Mahachai Hospital PCL in the upper half of its industry. The industry median EBITDA Margin % is 10.24. Mahachai Hospital PCL's value of 17.57% is 71.7% above this benchmark. Historically, Mahachai Hospital PCL's own EBITDA Margin % has ranged from 9.10 to 23.99 over the past decade. While the company's 10-year median is 17.79 vs. the industry median of 10.24, Mahachai Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mahachai Hospital PCL's current EBITDA Margin % of 17.57% is 71.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Mahachai Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mahachai Hospital PCL's current EBITDA Margin % is 17.57%, which is near median its own 10-year median of 17.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mahachai Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Mahachai Hospital PCL (BKK:M-CHAI) is currently considered Possible Value Trap. The stock's GF Value™ is ฿28.66, compared to a current price of ฿19.40 — trading 32.3% below its estimated fair value. The current EBITDA Margin % is 17.57%, which is near median its 10-year median of 17.79 and 71.7% above the Healthcare Providers & Services industry median of 10.24. Mahachai Hospital PCL's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Mahachai Hospital PCL (BKK:M-CHAI), the current EBITDA Margin % is 17.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mahachai Hospital PCL (BKK:M-CHAI) Overvalued in 2026?
Based on GuruFocus' analysis, Mahachai Hospital PCL stock appears to be undervalued.
The current stock price of ฿19.40 is trading 32.3% below its estimated GF Value™ of ฿28.66.
GuruFocus considers Mahachai Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:M-CHAI:
EBITDA Margin %: 17.57% (near median its 10-year median of 17.79)
GF Value™: ฿28.66 vs. price of ฿19.40 (32.3% below fair value)
Industry Position: 71.7% above the Healthcare Providers & Services median (#198 of 666)
No single metric tells the full story. See the BKK:M-CHAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mahachai Hospital PCL is a Thailand-based company offering medical services. It operates in the hospital and medical trading business. The company is engaged in operating a private hospital under the name of Mahachai Hospital. It offers various medical services, including a urology clinic, blood and cancer clinic, surgery, obstetrics and gynecology, ear, nose, and throat clinic, general clinic, dental and implants center, skin and beauty center, and physical department. The company operates in Thailand only.
73GF Score
Get the complete analysis for BKK:M-CHAI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:M-CHAI has been successfully added to your 
